Compound's dual action inhibited oral cancer, rat study finds
Thursday, October 18, 2012 - 12:04
in Health & Medicine
The compound licofelone inhibited oral cancer growth by inhibiting the cyclooxygenase and 5-lipoxygenase pathways, with no observable side effects, according to a recent rat study.